Outcomes4Me Secures $21M in Funding Learn more >>

Patient Login
Patient Sign Up
Log out
Go to Patient Dashboard
Go to Dashboard
Patient Login
Patient Sign Up
Log out
Go to Patient Dashboard
Go to Dashboard

Learn | Resources to take control of your cancer

Explore articles on personalized treatment options, clinical trials,
and symptom management to empower every step of your journey.
Mammogram procedure in medical clinic, mammography. Female mammologist positions mature woman at imaging machine to receive mammogram

When to start mammograms: Screening advice from Dr. Amy Kelly

Breast imaging is a complex topic that can be difficult to navigate. We had the...
doctor consulting older woman

Understanding side effects caused by HER2+ breast cancer treatment

Safety outcomes with first-line treatment of Enhertu (fam-trastuzumab deruxtecan-nxki; T-DXd) plus Perjeta (pertuzumab) is comparable...
woman relaxing on the couch looking at phone

8 health insurance benefits to claim after breast cancer

8 health insurance benefits to ask for after breast cancerA breast cancer diagnosis doesn’t just...
male doctor consulting with an older female patient in office

How do CDK 4/6 inhibitors work for hormone receptor-positive, HER2-negative metastatic breast cancer?

CDK 4/6 inhibitor side effects, treatment length, and moreDr. Pooja Advani is a breast oncologist...
Ask the Expert Webinar Series image thumbnail

Ask the Expert: Questions to ask your breast imaging radiologist

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses...
DNA test concept, genetic profiling background

ASCO 2025: Enhertu remains efficacious regardless of mutation status in HER2-low, ultra-low metastatic breast cancer

Enhertu (fam-trastuzumab deruxtecan-nxki or T-DXd) has shown promising results in slowing down or stopping the...
older woman looking at tablet at home

ASCO 2025: A glimpse into the future of breast cancer care

The American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 30...
A scientist placing a slide under a microscope close up

ASCO 2025: Re-evaluating HER2 levels in ER-positive breast cancer

A recent study is aiming to understand and classify the HER2 protein levels in breast...
doctor researchers working together in medical lab

ASCO 2025: Using artificial intelligence in HER2-low breast cancer pathology

One of the most important first steps after receiving a breast cancer diagnosis is understanding...
close up of an older woman gazing away from camera

What every hormone positive survivor should know

Could my cancer still come back?You finish treatment. You count the years. You start to...

Recognizing the Early Signs of Metastatic Breast Cancer

Learn the 7 early warning signs of metastatic breast cancer, including pain, fatigue, and new symptoms. Spot the red flags early and take action.
Doctor showing tablet to senior female patient

New hormone blockers for HR+ metastatic breast cancer treatment

Improving treatment outcomes in HR+ metastatic breast cancerIf you’re living with hormone receptor-positive (HR+) metastatic...
patient sitting in exam room talking to doctor

How effective are CDK 4/6 inhibitors in treating metastatic breast cancer?

 CDK 4/6 inhibitors: Monitoring effectiveness and resistanceFor patients with hormone receptor-positive, HER2-negative, metastatic breast cancer,...
Mature adult female doctor sitting at the desk in an office and discussing test results with senior woman.

Where does breast cancer spread To first?

What is HR+ metastatic breast cancer?When you hear the words hormone receptor-positive metastatic breast cancer...
munich germany skyline during the day

Key Takeaways from ESMO 2025 Breast Cancer Conference

The European Society of Medical Oncologists (ESMO) hosted its 2025 ESMO Breast Cancer meeting from...